Author

Jieqi Tu

University of Illinois ChicagoORCID 0000-0002-0905-0798Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:metabolomics· 1 Organism:mouse· 1 Assay:multiome· 1

Frequent Co-Authors

InSug O‐SullivaniD· 1 shared Joanne Kramer TobacmaniD· 1 shared Sumit BhattacharyyaiD· 1 shared Zhengjia CheniD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

InSug O‐SullivanORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyBiochimica et Biophysica Acta (BBA) - Molecular Basis of DiseasePeer-reviewedOct 7, 2023

Exogenous Recombinant N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B; ARSB) Inhibits Progression of B16F10 Cutaneous Melanomas and Modulates Cell Signaling

Sumit Bhattacharyya, InSug O‐Sullivan, Jieqi Tu…·Joanne Kramer Tobacman

This study shows that exogenous ARSB treatment reduces B16F10 melanoma tumor size and improves survival by altering chondroitin sulfate levels and modulating cell signaling pathways.

9 citations

mousehuman

𝕏 PostBluesky